W J van der Vijgh

1.8k total citations
23 papers, 1.4k citations indexed

About

W J van der Vijgh is a scholar working on Pathology and Forensic Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, W J van der Vijgh has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in W J van der Vijgh's work include Cancer Treatment and Pharmacology (9 papers), Vitamin D Research Studies (6 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). W J van der Vijgh is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Vitamin D Research Studies (6 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). W J van der Vijgh collaborates with scholars based in Netherlands, United States and United Kingdom. W J van der Vijgh's co-authors include Paul Lips, J. C. Netelenbos, Herbert M. Pinedo, L.M. Bouter, Jan C. Roos, P.D. Bezemer, Marius Ooms, M. Jongen, F C van Ginkel and I. Klein and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

W J van der Vijgh

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W J van der Vijgh Netherlands	18	654	488	406	233	224	23	1.4k
W. H. L. Hackeng Netherlands	22	528 0.8×	195 0.4×	358 0.9×	286 1.2×	227 1.0×	73	2.0k
Margaret C. Evans New Zealand	20	595 0.9×	441 0.9×	1.3k 3.2×	404 1.7×	187 0.8×	30	2.2k
Pablo Ureña‐Torres France	29	540 0.8×	371 0.8×	469 1.2×	300 1.3×	483 2.2×	81	2.6k
R. Giorgino Italy	20	345 0.5×	171 0.4×	447 1.1×	323 1.4×	142 0.6×	47	1.8k
Noboru Kubodera Japan	25	1.3k 2.1×	407 0.8×	471 1.2×	584 2.5×	275 1.2×	107	2.3k
J C Gazet United Kingdom	20	386 0.6×	578 1.2×	113 0.3×	207 0.9×	78 0.3×	62	1.8k
E. Delvin Canada	20	216 0.3×	237 0.5×	93 0.2×	274 1.2×	168 0.8×	43	1.1k
R. J. Walton United Kingdom	17	307 0.5×	506 1.0×	206 0.5×	279 1.2×	198 0.9×	47	1.8k
Nina H. Bjarnason Denmark	11	259 0.4×	785 1.6×	868 2.1×	619 2.7×	42 0.2×	18	2.2k
Oleg Tsuprykov Germany	22	320 0.5×	169 0.3×	70 0.2×	216 0.9×	90 0.4×	33	1.2k

Countries citing papers authored by W J van der Vijgh

Since Specialization

Citations

This map shows the geographic impact of W J van der Vijgh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W J van der Vijgh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W J van der Vijgh more than expected).

Fields of papers citing papers by W J van der Vijgh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W J van der Vijgh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W J van der Vijgh. The network helps show where W J van der Vijgh may publish in the future.

Co-authorship network of co-authors of W J van der Vijgh

This figure shows the co-authorship network connecting the top 25 collaborators of W J van der Vijgh. A scholar is included among the top collaborators of W J van der Vijgh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W J van der Vijgh. W J van der Vijgh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacobs, H. Kurt, Ger H. Koek, Ron Peters, et al.. (2011). Differences in Pharmacological Activities of the Antioxidant Flavonoid MonoHER in Humans and Mice Are Caused by Variations in Its Metabolic Profile. Clinical Pharmacology & Therapeutics. 90(6). 852–859. 9 indexed citations

Groeningen, Cees J. van, et al.. (2005). A phase I study of monohydroxyethylrutoside in healthy volunteers. Cancer Chemotherapy and Pharmacology. 57(5). 678–684. 23 indexed citations

Groeningen, C.J. van, W J van der Vijgh, Jan Baars, et al.. (2000). Altered pharmacokinetics and metabolism of CPT-11 in liver dysfunction: a need for guidelines.. PubMed. 6(4). 1342–6. 20 indexed citations

Huizing, Manon, Giuseppe Giaccone, Laurence J. van Warmerdam, et al.. (1997). Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.. Journal of Clinical Oncology. 15(1). 317–329. 159 indexed citations

Sips, Adriënne J.A.M., Rob Barto, J. C. Netelenbos, & W J van der Vijgh. (1997). Preclinical screening of the applicability of strontium as a marker for intestinal calcium absorption. American Journal of Physiology-Endocrinology and Metabolism. 272(3). E422–E428. 15 indexed citations

Sips, Adriënne J.A.M., W J van der Vijgh, Rob Barto, & J. C. Netelenbos. (1995). Intestinal strontium absorption: from bioavailability to validation of a simple test representative for intestinal calcium absorption. Clinical Chemistry. 41(10). 1446–1450. 21 indexed citations

Barto, Rob, Adriënne J.A.M. Sips, W J van der Vijgh, & J. C. Netelenbos. (1995). Sensitive method for analysis of strontium in human and animal plasma by graphite furnace atomic absorption spectrophotometry. Clinical Chemistry. 41(8). 1159–1163. 15 indexed citations

Calvert, Hilary, I. Judson, & W J van der Vijgh. (1993). Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity.. PubMed. 17. 189–217. 68 indexed citations

Jong, Jan de, et al.. (1992). Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a phase I clinical trial.. Journal of Clinical Oncology. 10(12). 1897–1906. 25 indexed citations

10.

Ratain, Mark J., Jacques Robert, & W J van der Vijgh. (1991). Limited sampling models for doxorubicin pharmacokinetics.. Journal of Clinical Oncology. 9(5). 871–876. 36 indexed citations

11.

Jong, Jan de, et al.. (1990). Isolated mouse atrium as a model to study anthracycline cardiotoxicity: the role of the beta-adrenoceptor system and reactive oxygen species.. PubMed. 68(3). 275–89. 18 indexed citations

12.

Mross, K., Paul A. Maessen, W J van der Vijgh, et al.. (1988). Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans.. Journal of Clinical Oncology. 6(3). 517–526. 156 indexed citations

13.

Lips, Paul, et al.. (1987). Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. American Journal of Clinical Nutrition. 46(6). 1005–1010. 175 indexed citations

14.

Vijgh, W J van der, I. Klein, F. Elferink, et al.. (1987). Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.. PubMed. 47(23). 6297–301. 75 indexed citations

15.

Elferink, F., W J van der Vijgh, I. Klein, & Herbert M. Pinedo. (1986). Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding.. Clinical Chemistry. 32(4). 641–645. 68 indexed citations

16.

Jongen, M., F C van Ginkel, W J van der Vijgh, et al.. (1984). An international comparison of vitamin D metabolite measurements.. Clinical Chemistry. 30(3). 399–403. 53 indexed citations

17.

Jongen, M., W J van der Vijgh, Hanny Willems, & J. C. Netelenbos. (1981). Analysis for 1,25-dihydroxyvitamin D in human plasma, after a liquid-chromatographic purification procedure, with a modified competitive protein-binding assay.. Clinical Chemistry. 27(3). 444–450. 39 indexed citations

18.

Jongen, M., W J van der Vijgh, Hanny Willems, J. C. Netelenbos, & Paul Lips. (1981). Simultaneous determination of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D in plasma or serum.. Clinical Chemistry. 27(10). 1757–1760. 29 indexed citations

19.

Vijgh, W J van der & P. L. Oe. (1978). Pharmacokinetic aspects of digoxin in patients with terminal renal failure. IV. Clinical implications of own observations with a recent review of literature.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(11). 540–6. 1 indexed citations

20.

Vijgh, W J van der. (1977). Pharmacokinetic aspects of digoxin in patients with terminal renal failure. II. On hemodialysis.. PubMed. 15(6). 255–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact